[{"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "70 ml", "code_info": "All lots distributed between November 2014 and May 2015;  03122015@23, 6/10/2015; 04092015@73, 6/8/2015; 05082015@39, 7/7/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Morphine 50 mg/ml + Fentanyl 20,000 mcg/ml + Bupivacaine 30 mg/ml + Clonidine 1,200 mcg/ml Solution, Sterile, Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1712-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1183-2019", "product_description": "Methylcobalamin 3000 mcg/mL Injection Solution, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "N/A", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"status": "Terminated", "city": "Williamstown", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "66406", "recalling_firm": "Haute Health, LLC", "address_1": "614 Atlanta Ct", "address_2": "N/A", "postal_code": "08094-3549", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide and internationally via internet sales.", "recall_number": "D-1235-2014", "product_description": "Prolifta Dietary Supplement Prolifta, 400mg/capsule, Packaged in 1 and 2 capsule blister packs and 4, 12, and 24 capsule bottles   Made in the USA Distributed by: Prolifta LLC 1+877.239.8231  www.proliftaherbal.com.", "product_quantity": "172,800 capsules", "reason_for_recall": "Marketed without an Approved NDA/ANDA: Dietary supplement may contain amounts of an active ingredient found in some FDA-approved drugs for erectile dysfunction (ED) making the dietary supplement an unapproved drug.", "recall_initiation_date": "20130927", "center_classification_date": "20140415", "termination_date": "20150129", "report_date": "20140423", "code_info": "All lot codes and expiration dates."}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: SODIUM CHLORIDE, Tablet, 1000 mg may have potentially been mislabeled as the following drug:  REPAGLINIDE, Tablet, 2 mg, NDC 00169008481, Pedigree: W003925, EXP: 7/1/2014.", "address_2": "", "product_quantity": "1000 Tablets", "code_info": "SODIUM CHLORIDE, Tablet, 1000 mg has the following codes:   Pedigree: W003925, EXP: 7/1/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "SODIUM CHLORIDE, Tablet, 1000 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00527111610", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-918-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Abbott Park", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021402"], "brand_name": ["SYNTHROID"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["AbbVie Inc."], "product_ndc": ["0074-3727", "0074-4341", "0074-4552", "0074-5182", "0074-6594", "0074-6624", "0074-9296", "0074-7068", "0074-7069", "0074-7070", "0074-7148", "0074-7149"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966158", "966171", "966185", "966191", "966201", "966205", "966218", "966220", "966221", "966222", "966224", "966225", "966247", "966248", "966249", "966250", "966251", "966253", "966270", "966271", "966282"], "spl_id": ["b85ab7fa-ba96-43cd-b736-44b3924e644c"], "spl_set_id": ["1e11ad30-1041-4520-10b0-8f9d30d30fcc"], "package_ndc": ["0074-4341-13", "0074-4341-90", "0074-4341-19", "0074-4341-72", "0074-4552-13", "0074-4552-90", "0074-4552-19", "0074-4552-11", "0074-4552-71", "0074-4552-72", "0074-5182-13", "0074-5182-90", "0074-5182-71", "0074-5182-19", "0074-5182-11", "0074-5182-72", "0074-6594-13", "0074-6594-90", "0074-6594-71", "0074-6594-19", "0074-6594-72", "0074-6624-13", "0074-6624-90", "0074-6624-19", "0074-6624-11", "0074-6624-71", "0074-6624-72", "0074-9296-13", "0074-9296-90", "0074-9296-19", "0074-9296-71", "0074-9296-72", "0074-7068-13", "0074-7068-90", "0074-7068-71", "0074-7068-19", "0074-7068-11", "0074-7068-72", "0074-3727-13", "0074-3727-90", "0074-3727-71", "0074-3727-19", "0074-3727-72", "0074-7069-90", "0074-7069-71", "0074-7069-19", "0074-7069-11", "0074-7069-72", "0074-7070-13", "0074-7070-90", "0074-7070-71", "0074-7070-19", "0074-7070-72", "0074-7148-90", "0074-7148-19", "0074-7148-71", "0074-7148-11", "0074-7148-72", "0074-7149-90", "0074-7149-19"], "is_original_packager": [true], "upc": ["0300747070190", "0300747069903", "0300749296192", "0300743727906", "0300747148905", "0300746624905", "0300747149902", "0300747068197", "0300744341194", "0300745182192"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "62674", "recalling_firm": "Abbott Laboratories", "address_1": "100 Abbott Park Rd", "address_2": "N/A", "postal_code": "60064-3502", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1695-2012", "product_description": "Synthroid (levothyroxine sodium) Tablets USP, 75 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chicago, IL 60064, NDC: 0074-5182-90.", "product_quantity": "42,596 Bottles", "reason_for_recall": "Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.", "recall_initiation_date": "20120719", "center_classification_date": "20120926", "termination_date": "20131101", "report_date": "20121003", "code_info": "Lot: 18353A8, Exp 08/31/2013", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-904-2015", "product_description": "Streptomycin Sulfate or Sulphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "30500 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "24 pellets", "code_info": "All lots distributed between November 2014 and May 2015;  02192015@41, 8/18/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Testosterone 30 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1747-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0182-2018", "product_description": "Iodochlorhydroxyquin 3%/ Boric Acid 10%/ Amphotericin 5% Otic Powder packaged in jars, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "40 jars", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lot: 07282017@23 BUD: 1/24/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Ringwood", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82645", "recalling_firm": "Inopak Ltd", "address_1": "24 Executive Pkwy", "address_2": "N/A", "postal_code": "07456-1430", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1318-2019", "product_description": "Antibacterial Hand Soap, .3% P.C.M.X, labeled as STYLE Antibacterial Hand Soap with moisturizers, a) 1000 ml pouches, 10/1000 ML. Large Valve pouches per case, 5031-404-LN, b) 1000 ml pouches, 8/1000 ML. Disc Pumps pouches per case, 5031-L1000, c) 800 ML Universal Valve pouches, 12/800 ML Universal Valve pouches per case, 5031-404, d) 800 ml pouches, 12/800 ML Presspak pouches per case, \"B\", 5031-403-1B, e) 800 ml pouches, 12 x 800ML. KC Valve pouches per case, 5031-404-KC, f) 800 ml pouches, 12/800 ML Universal Valve pouches per case, 5031-404, g) 800 ml pouches, 12/800 ML Presspak pouches per case, \"B\", 5031-403-1B, h) 500 ml pouches, 6/500 ML. KC Valve pouches per case, 5031-404-500-6, i) 500 ml pouches, 18/500 ML. KC Valve pouches per case, 5031-404-500, j) 500 ml pouches, 6/500 ML. KC Valve pouches per case, 5031-404-500-6, k) 8 oz. bottles, 24/8 OZ. bottles with pumps per case, 5031-440-03, l) 18 oz. bottles, 16 x 18 OZ. Bottles with Pumps per case, 5031-430-02, m) 1000 ml pouches, 10/1000 ML. Large Valve pouches per case, 5031-404-LN, n) 1000 ml pouches, 8/1000ML. Disc Pumps pouches per case, 5031-L1000; Choice Antibacterial Hand Soap, packaged as o) 800 ml/27fl.oz. pouches, 12/800 ml Universal Valve pouches per case, 5031-404UV-CH, Manufactured by Inopak LTD., Ringwood, NJ.", "product_quantity": "17,850 pounds per batch", "reason_for_recall": "CGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.", "recall_initiation_date": "20190422", "center_classification_date": "20190529", "termination_date": "20240828", "report_date": "20190605", "code_info": "Batch #: 6660, 6664, 6676, 6682, 6685, 6698 ,6701, 6725, 6732, 6742, 6744, 6746, 6756, 6762, 6770, 6777, 6792, 6798, 6807, 6813, 6816, 6820, 6829, 6839, 6868, 6872, 6875, 6891, 6892, 6904, 6906, 6914, 6916, 6923, 6932, 6939, 6952, 6958, 6963, 6970, 6978, 6982, 6987, 6993, 6997, 7004, 7006, 7024, 7038, 7049, 7054, 7056, 7058, 7078, 7087, 7098, 7104, 7108, 7111, 7129, 7132, 7134, 7138, 7145, 7152, 7157, 7160, 7164, 7170, 7177, 7184, 7190, 7192, 7203, 7207, 7220, 7224, 7231, 7235, 7237, 7243, 7247, 7252, 7258, 7260, 7269, 7281, 7285, 7291, 7296, 7301, 7306, 7311, 7312, 7319, 7322, 7326, 7335, 7338, 7340, 7347, 7351, 7353, 7368, 7377, 7384, 7387, 7394 and 7399"}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1206-2020", "product_description": "Hydromorphone Oral 1 mg/mL Solution 240 mL, bottle, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 bottle", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 45163 Discard by: 9/1/2020", "more_code_info": ""}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90512", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1262-2022", "product_description": "Labetalol HCl Injection, USP, 20 mg/4 mL (5 mg/mL) syringe, packaged in 5 x 4 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-946-04", "product_quantity": "184,370 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220630", "center_classification_date": "20220718", "termination_date": "20240617", "report_date": "20220727", "code_info": "Lots: LB2002A, Exp. 7/12/2022; LB2004A, Exp. 8/21/2022; LB2006A, Exp. 9/3/2022; LB2008A, Exp. 10/6/2022"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0202-2019", "product_description": "Trimix Papaverine/Phentolamine/Alprostadil/Lidocaine 30 mg/1 mg/175 mcg/1 mg Powder Pharm D Solutions, Houston, Texas --- NDC 69699-1369-02", "product_quantity": "195 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 05302018:59 Discard by: 11/26/2018; 06132018:44 Discard by: 12/10/2018; 06062018:64 Discard by: 12/3/2018; 07262018:97 Discard by: 11/1/2018; 07052018:23 Discard by: 1/1/2019"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67881", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave", "address_2": "Suite A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1188-2014", "product_description": "HydrOXYzine HCl Tablets, USP  25 mg, 100 Tablet Blister, Rx only Mfd by: KVK-TECH, INC. Newtown, PA 18940, NDC 68084-254-01", "product_quantity": "14,665 blister packs", "reason_for_recall": "Good Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an  unapproved source.", "recall_initiation_date": "20140131", "center_classification_date": "20140403", "termination_date": "20150401", "report_date": "20140409", "code_info": "Lot 120407, Exp 01/14; Lot 121337 Exp 03/14; Lot 122054, Exp 05/14; Lot  122598, Exp 06/14;   Lot 130125, Exp 12/14"}, {"status": "Terminated", "city": "Wilmington", "state": "DE", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65543", "recalling_firm": "AstraZeneca Pharmaceuticals LP", "address_1": "1800 Concord Pike", "address_2": "N/A", "postal_code": "19850", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA and Puerto Rico", "recall_number": "D-840-2013", "product_description": "MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, Rx only, Mfd for: AstraZeneca Pharmaceuticals LP, Wilmington, DE by ACS Dobfar SpA Viale Addetta, Tribiano, Milano Italy NDC  0310 0321 30", "product_quantity": "81,900 total vials", "reason_for_recall": "Presence of Precipitate; potential for incomplete constitution upon addition of diluent.", "recall_initiation_date": "20130621", "center_classification_date": "20130805", "termination_date": "20150129", "report_date": "20130814", "code_info": "NDC 0310-321-30, lot JX109, expiration 2/2015; lot JY042, expiration 2/2015"}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74187", "recalling_firm": "Well Care Compounding Pharmacy", "address_1": "3430 E Tropicana Ave Ste 9", "address_2": "N/A", "postal_code": "89121-7345", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "NV", "recall_number": "D-0994-2016", "product_description": "M.l.C. 25MG/50MG/25MG/ML, packaged in 5mL vials, Rx only,   Well Care Compounding Pharmacy Las Vegas, NV 89121", "product_quantity": "869 Units (Total All Products)", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.", "recall_initiation_date": "20160517", "center_classification_date": "20160609", "termination_date": "20170113", "report_date": "20160615", "code_info": "Lot #: 01042016: 45@46, Exp. 07/02/2016; Lot #:01112016:   87@46, Exp. 07/10/2016; Lot #:01112016:78@63, Exp.   07/10/2016; Lot #: 01272016:81@30, Exp.07/25/2016; Lot #: 02102016:89@2, Exp. 08/08/2016; 02162016:25@57, Exp.08/14/2016; 02262016:33@54, Exp.08/24/2016; Lot #: 03092016:64@51, Exp.09/07/2016; Lot #: 04142016:01@45, Exp.10/11/2016  04142016:17@37, Exp.10/15/2016; 04282016:72@48, Exp.10/29/2016."}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0206-2019", "product_description": "Trimix ST9D 30PA-2PH-150A Aqueous Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1311-03", "product_quantity": "336 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 04102018:12 Discard by: 10/7/2018; 05102018:06 Discard by: 11/6/2018; 05222018:76 Discard by: 11/18/2018; 07022018:35 Discard by: 12/29/2018; 08272018:00 Discard by: 1/14/2019; 08082018:14 Discard by: 2/4/2019"}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81218", "recalling_firm": "Sprayology", "address_1": "18914 Bonanza Way", "address_2": "N/A", "postal_code": "20879-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0115-2019", "product_description": "TravelEase, Homeopathic Oral Spray, 1.38 fl. oz (41ml), Manufactured for Sprayology Gaithersburg. MD 20879NDC 61096-0007-1. and Tester NDC 61096-1007-1", "product_quantity": "1,307 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20181009", "center_classification_date": "20181030", "termination_date": "20190418", "report_date": "20181107", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1806-2019", "product_description": "PRESERVATIVE FREE 0.9% NACL 5 ML SYR, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Ongoing", "city": "Massena", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "generic_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "manufacturer_name": ["CHAIN DRUG MARKETING ASSOCIATION INC."], "product_ndc": ["63868-607"], "product_type": ["HUMAN OTC DRUG"], "route": ["NASAL"], "substance_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "rxcui": ["1000990"], "spl_id": ["b20bf193-c444-44c8-8fea-012de3f835f4"], "spl_set_id": ["2ee2b332-9b85-45a6-b242-3f0ebfbd08a6"], "package_ndc": ["63868-607-01"], "is_original_packager": [true], "upc": ["0635515988446", "635515988439", "840986035098"], "unii": ["K89MJ0S5VY"]}, "product_type": "Drugs", "event_id": "93708", "recalling_firm": "Seaway Pharma Inc.", "address_1": "5 County Route 42", "address_2": "N/A", "postal_code": "13662-1569", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MI, PA", "recall_number": "D-0214-2024", "product_description": "Nasal Spray Original No Drip Oxymetazoline HCl Nasal Solution, 12 Hour Pump Mist, 1 FL oz. (30 mL) bottle, a) Quality Choice, Distributed by C.D.M.A. Inc., 43157 W 9 Mile Rd, Novi, MI 48375, NDC# 63868-607-01, UPC 6-35515-98843-9, b) Premier Value, Distributed by: Pharmacy Value Alliance, LLC, 407 East Lancaster Avenue, Wayne, PA 19087 UPC 8-40986-03509-8.", "product_quantity": "7,992 bottles", "reason_for_recall": "CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.", "recall_initiation_date": "20231228", "center_classification_date": "20240104", "report_date": "20240110", "code_info": "Lot # SD23032, Exp 04/30/2026"}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA072204"], "brand_name": ["LOXAPINE"], "generic_name": ["LOXAPINE"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-0369", "0591-0370", "0591-0371", "0591-0372"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LOXAPINE SUCCINATE"], "rxcui": ["311385", "311386", "314075", "314078"], "spl_id": ["cae2db34-6be2-45cf-b9b5-9b929650eb4f"], "spl_set_id": ["a6107bb1-3e23-4c5d-bbf4-5e29deff6728"], "package_ndc": ["0591-0369-01", "0591-0370-01", "0591-0371-01", "0591-0372-01"], "is_original_packager": [true], "upc": ["0305910369019", "0305910370015", "0305910372019"], "unii": ["X59SG0MRYU"]}, "product_type": "Drugs", "event_id": "62383", "recalling_firm": "Watson Laboratories Inc", "address_1": "311 Bonnie Cir", "address_2": "N/A", "postal_code": "92880-2882", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1400-2012", "product_description": "Loxapine Capsules USP, 10mg, 100 count bottle, Rx only, Manufactured By: Watson Laboratories Inc., Corona, CA 92880 Rx only. NDC #  0591-0370-01", "product_quantity": "106,323 bottles", "reason_for_recall": "Labeling: Incorrect or Missing Package Insert:  An outdated version of a patient outsert was used when packaged.", "recall_initiation_date": "20120417", "center_classification_date": "20120629", "termination_date": "20130318", "report_date": "20120711", "code_info": "Lot #s: 107886A, 107887A, 112874A, 144274A, 196483A, 201146A, 217265A, 260747B, 283308A, 313279A, 313279B, 327892A, 327893A, 327894A, 387239A, 387240A, 427259A, 427260A, 456251A."}, {"country": "United States", "city": "Berkeley", "address_1": "2320 Woolsey St", "reason_for_recall": "Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.", "address_2": "", "product_quantity": "36 ml", "code_info": "All lots", "center_classification_date": "20160217", "distribution_pattern": "CA", "state": "CA", "product_description": "testosterone cypionate, 200 mg/mL, 6 mL and 10 mL unit sizes, This Rx is Compounded, Abbott's Compounding Pharmacy, Berkeley, CA 94705", "report_date": "20160224", "classification": "Class II", "openfda": {}, "recalling_firm": "Abbott's Compounding Pharmacy, Inc.", "recall_number": "D-0716-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73090", "termination_date": "20170406", "more_code_info": "", "recall_initiation_date": "20160115", "postal_code": "94705-1973", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "208 vials", "code_info": "Lot #: a) Zinc Sulfate 10 mg/30 mL: 20130404-A, Exp  7/4/2013; b) Zinc Sulfate 1 mg/10 mL: 20130206-B, Exp 5/6/2013  .", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Zinc Sulfate Injection, all strengths and all presentations including a) Zinc Sulfate 10 mg/mL 30 mL and b) Zinc Sulfate 1 mg/mL 10 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-416-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69539", "recalling_firm": "West-Ward Pharmaceutical Corp.", "address_1": "465 Industrial Way W", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "GA", "recall_number": "D-0172-2015", "product_description": "VERSAPHARM INCORPORATED Ethambutol Hydrochloride Tablets, USP, 100 mg, 100-count bottle, Rx Only, Manufactured for VersaPharm Incorporated Marietta, GA 30065-1509 Manufactured by West-ward Pharmaceutical Corp. Eatontown, NJ 07724, NDC 61748-011-01", "product_quantity": "5,596 HDPE bottles", "reason_for_recall": "Subpotency: Out of Specification (OOS) result at the 36 month routine stability time point.", "recall_initiation_date": "20141002", "center_classification_date": "20141030", "termination_date": "20150803", "report_date": "20141105", "code_info": "Lot #68975A, #68976; Exp. 07/15", "more_code_info": ""}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80550", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States", "recall_number": "D-1074-2018", "product_description": "Omega-3-Acid Ethyl Esters Capsules USP, 1 gram* 120-count bottle  Rx Only. Manufactured by: Banner Pharmacaps, Inc. High Point, NC 27265. Manufactured for: Teva Pharmaceuticals USA Inc. North Wales, PA 19454 NDC 0093-5401-89", "product_quantity": "13,715 120-count bottles", "reason_for_recall": "API material used in the manufacturing of the product did not receive regulatory approval prior to release.", "recall_initiation_date": "20180716", "center_classification_date": "20180808", "termination_date": "20190328", "report_date": "20180815", "code_info": "Lot # 150001420A, EXP 2/2019"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; LACTOBACILLUS GG Capsule may be potentially mislabeled as    VITAMIN B COMPLEX W/C, Capsule, NDC 54629008001, Pedigree: AD39560_4, EXP: 5/13/2014;  DOCUSATE SODIUM, Capsule, 50 mg, NDC 67618010060, Pedigree: AD65457_13, EXP: 5/24/2014;  VITAMIN B COMPLEX WITH C/FOLIC ACID, Tablet, NDC 60258016001, Pedigree: AD70655_17, EXP: 5/28/2014;  TACROLIMUS, Capsule, 1 mg, NDC 00781210", "address_2": "", "product_quantity": "1,970 Capsules", "code_info": "LACTOBACILLUS GG, Capsule has the following codes    Pedigree: AD39588_4, EXP: 5/13/2014  Pedigree: AD65457_16, EXP: 5/24/2014  Pedigree: AD70655_8, EXP: 5/29/2014  Pedigree: AD73627_17, EXP: 5/30/2014  Pedigree: W003051, EXP: 6/12/2014  Pedigree: W003216, EXP: 6/14/2014  Pedigree: AD42584_12, EXP: 5/14/2014  Pedigree: AD46300_11, EXP: 5/15/2014  Pedigree: W002968, EXP: 6/11/2014  Pedigree: AD68019_1, EXP: 5/28/2014  Pedigree: W003172, EXP: 6/13/2014  Pedigree: W003173, EXP: 6/13/2014", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LACTOBACILLUS GG Capsule, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 49100036374", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-579-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "New Albany", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090534"], "brand_name": ["NICARDIPINE HYDROCHLORIDE"], "generic_name": ["NICARDIPINE HYDROCHLORIDE"], "manufacturer_name": ["Civica, Inc."], "product_ndc": ["72572-470"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["NICARDIPINE HYDROCHLORIDE"], "rxcui": ["858607"], "spl_id": ["fba70df6-5d37-4a12-bce3-e6fb1b0c72b2"], "spl_set_id": ["30fb3a4d-fa75-42fd-b4b6-2a21f202027f"], "package_ndc": ["72572-470-01", "72572-470-10"], "is_original_packager": [true], "unii": ["K5BC5011K3"]}, "product_type": "Drugs", "event_id": "96695", "recalling_firm": "American Regent, Inc.", "address_1": "6610 New Albany Rd E", "address_2": "N/A", "postal_code": "43054-8730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0398-2025", "product_description": "niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, Mfd for: Civica, Inc., Lehi, UT 84043,Mfd by: American Regent, Inc., New Albany, OH 43064. NDC Carton: 72572-470-10/ NDC Vial: 72572-470-01.", "product_quantity": "29,777 (cartons of 10 x 10mL vials)", "reason_for_recall": "Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.", "recall_initiation_date": "20250418", "center_classification_date": "20250501", "report_date": "20250507", "code_info": "Lots, expiry: Lot 24025N0C0, 6/30/2025; Lot 24115N0C0, 10/31/2025; Lot 24116N0C0, 3/31/2026; Lot 24160N0C0, 12/31/2025; Lot 24217N0C0, 01/31/2026; Lot 24288N0C0, 04/30/2026; Lot 24331N0C0, 5/31/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77374", "recalling_firm": "Pharmedium Services Llc", "address_1": "150 N Field Dr", "address_2": "N/A", "postal_code": "60045-4847", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0932-2017", "product_description": "Ropivacaine HCl 0.2% 500 mL Total Volume in an ON-Q Pump in 0.9% Sodium Chloride Injection in 400 mL, Rx Only, Compounded by PharMEDium Services, LLC, Sugar Land, TX 77478, NDC: 61553-258-25", "product_quantity": "147 I.V. pumps", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date", "recall_initiation_date": "20170215", "center_classification_date": "20170702", "termination_date": "20200113", "report_date": "20170712", "code_info": "Lot: 170270192s  Lot: 170330167s  Lot: 170320087s Ex.: 01/01/1900"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; SODIUM BICARBONATE Tablet, 650 mg may be potentially mislabeled as    NICOTINE POLACRILEX, Lozenge, 2 mg, NDC 00135051001, Pedigree: W002974, EXP: 6/11/2014.", "address_2": "", "product_quantity": "1,013 Tablets", "code_info": "SODIUM BICARBONATE Tablet, 650 mg has the following code    Pedigree: W002970, EXP: 6/11/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "SODIUM BICARBONATE Tablet, 650 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 64980018210", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-704-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "New Brunswick", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "91381", "recalling_firm": "Spectrum Laboratory Products, Inc.", "address_1": "755, 769 And 777 Jersey Ave", "address_2": "N/A", "postal_code": "08901-3605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Puerto Rico and Canada", "recall_number": "D-0180-2023", "product_description": "Epinephrine (L-Adrenaline), USP, CAS 51-43-4, Packaged in amber glass bottles in a vacuum sealed pouch as (a)100 G; (b)1 G, (c) 25 G, (d) 5 G; Rx only. Repackaged by Spectrum Chemical Mfg. Corp. Gardena, CA 90248; New Brunswick, NJ 08901.", "product_quantity": "7 x 100G; 17 x  1G; 6 x 25G; 20 x 5G", "reason_for_recall": "Discoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in less effective product", "recall_initiation_date": "20221219", "center_classification_date": "20230125", "termination_date": "20250819", "report_date": "20230201", "code_info": "Lot # (a) (b) (c) (d) lot 2KL0353, EXP 30-Sep-2023; 2KF0151, EXP 31-Mar-2023", "more_code_info": ""}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72179", "recalling_firm": "US Compounding Inc", "address_1": "1270 Don's Lane", "address_2": "N/A", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0243-2016", "product_description": "Brompheniramine Maleate (10 mg/mL), 10 mL Multi-Dose Vial, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-3019-07", "product_quantity": "589 vials.", "reason_for_recall": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.", "recall_initiation_date": "20150912", "center_classification_date": "20151117", "termination_date": "20170330", "report_date": "20151125", "code_info": "Lot Numbers: 20151205@11 BUD: 11/7/2015; 20151806@11 BUD: 12/15/2015"}, {"status": "Terminated", "city": "Ringwood", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78098", "recalling_firm": "Inopak Ltd", "address_1": "24 Executive Pkwy", "address_2": "N/A", "postal_code": "07456-1430", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "nationwide", "recall_number": "D-0003-2018", "product_description": "Mild Healthcare Antibacterial Hand Soap, 6% P.C.M.X., 1000 mL and 2000 mL Disc Pump,  800 mL Universal Valve, and 1 gallon bottles, Inopak. Ltd, Ringwood, NJ 07456", "product_quantity": "N/A", "reason_for_recall": "GMP Deviations; potential bacterial contamination may have been introduced to products through a contaminated diaphragm pump.", "recall_initiation_date": "20170823", "center_classification_date": "20171004", "termination_date": "20200420", "report_date": "20171011", "code_info": "Batch Numbers \u0013 6749, 6909", "more_code_info": ""}, {"status": "Ongoing", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "94265", "recalling_firm": "Pyramids Wholesale Inc.", "address_1": "464 E 4th St", "address_2": "N/A", "postal_code": "90013-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0451-2024", "product_description": "Samurai-X Honey 6800, UPC 2 56891 27553 3.", "product_quantity": "N/A", "reason_for_recall": "Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.", "recall_initiation_date": "20240319", "center_classification_date": "20240422", "report_date": "20240501", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021446"], "brand_name": ["LYRICA"], "generic_name": ["PREGABALIN"], "manufacturer_name": ["Parke-Davis Div of Pfizer Inc"], "product_ndc": ["0071-1012", "0071-1013", "0071-1014", "0071-1015", "0071-1016", "0071-1017", "0071-1019", "0071-1018", "0071-1020"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PREGABALIN"], "rxcui": ["483438", "483440", "483442", "483444", "483446", "483448", "483450", "577127", "607018", "607020", "607022", "607024", "607026", "607028", "607033", "607038", "898715", "898718"], "spl_id": ["e7c79058-03ba-4e7f-9a31-9ec5ce245161"], "spl_set_id": ["60185c88-ecfd-46f9-adb9-b97c6b00a553"], "package_ndc": ["0071-1012-68", "0071-1013-41", "0071-1013-68", "0071-1014-41", "0071-1014-68", "0071-1015-41", "0071-1015-68", "0071-1016-41", "0071-1016-68", "0071-1017-68", "0071-1019-68", "0071-1018-68", "0071-1020-01"], "is_original_packager": [true], "upc": ["0300711012683"], "unii": ["55JG375S6M"]}, "product_type": "Drugs", "event_id": "73043", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0649-2016", "product_description": "Lyrica (pregabalin) capsules, 75 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1014-68", "product_quantity": "116,400 bottles", "reason_for_recall": "FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules.", "recall_initiation_date": "20160111", "center_classification_date": "20160201", "termination_date": "20170424", "report_date": "20160210", "code_info": "Lot #: M07862, Exp 05/2018;  M07865, Exp 06/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-545-2015", "product_description": "Bismuth Subcarbonate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "25000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Canton", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95427", "recalling_firm": "Fresenius Kabi Compounding, LLC", "address_1": "20 Dan Rd", "address_2": "N/A", "postal_code": "02021-2809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 125 direct accounts nationwide.", "recall_number": "D-0021-2025", "product_description": "Oxytocin 0.9% Sodium Chloride Injection USP, 30 units per 500 mL Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-028-59", "product_quantity": "4436 bags", "reason_for_recall": "cGMP violations", "recall_initiation_date": "20240925", "center_classification_date": "20241021", "termination_date": "20250815", "report_date": "20241030", "code_info": "Lot # C274-000038801, exp. date 9-Oct-24 C274-000039045, exp. date 24-Oct-24 C274-000039240, exp. date 31-Oct-24", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; SEVELAMER HCl Tablet, 800 mg may be potentially mislabeled as    RANOLAZINE ER, Tablet, 500 mg, NDC 61958100301, Pedigree: W002857, EXP: 6/7/2014.", "address_2": "", "product_quantity": "180 Tablets", "code_info": "SEVELAMER HCl Tablet, 800 mg has the following code    Pedigree: W002858, EXP: 6/7/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "SEVELAMER HCl Tablet, 800 mg, Rx only, Distributed by: AidaPak Service, LLC,  NDC 58468002101", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-636-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Commerce", "address_1": "5560 E 61st St", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: product may contain undeclared sildenafil, tadalafil and analogues of these FDA approved active ingredients, making them unapproved drugs", "address_2": "", "product_quantity": "96,000 capsules.", "code_info": "Lot# 030112, Exp: 03/15", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "CA", "product_description": "CASANOVA Capsules, 450 mg, MALE SEXUAL ENHANCER, supplied i n1 count blister packs, UPC 736211906892; Distributed by: Casanova Distributors, Tucker, GA", "report_date": "20130522", "classification": "Class I", "openfda": {}, "recalling_firm": "Performance Plus Marketing, Inc.", "recall_number": "D-338-2013", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "63916", "termination_date": "20131114", "more_code_info": "", "recall_initiation_date": "20121217", "postal_code": "90040-3406", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0060-2020", "product_description": "Hyaluronidase (PF) Ophthalmic Injection 450 Units/3 mL (150 Units/mL) 3 mL Fill in a 5 mL Single Dose Vial, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678359", "product_quantity": "928 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Woodcliff Lake", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["505G(a)(3)"], "brand_name": ["PVP IODINE PREP PAD"], "generic_name": ["PROVIDONE IODINE"], "manufacturer_name": ["Professional Disposables International, Inc."], "product_ndc": ["10819-3883", "10819-3885"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["POVIDONE-IODINE"], "rxcui": ["797730"], "spl_id": ["40ab78fb-f19d-ce27-e063-6294a90ae51d"], "spl_set_id": ["50c524ab-7029-494a-8bb4-d90a4d184fb2"], "package_ndc": ["10819-3883-1", "10819-3883-3", "10819-3885-1", "10819-3885-2", "0031081900"], "is_original_packager": [true], "nui": ["N0000175486", "M0011640"], "pharm_class_epc": ["Antiseptic [EPC]"], "pharm_class_cs": ["Iodine [CS]"], "unii": ["85H0HZU99M"]}, "product_type": "Drugs", "event_id": "88326", "recalling_firm": "Professional Disposables International, Inc", "address_1": "400 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "07677-7604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the US", "recall_number": "D-0759-2021", "product_description": "PDI Povidone-Iodine Prep Pad Large, 1 Prep Pad, Professional Disposable International, Inc., Orangeburg, NY 10962 -1376 USA Reorder No C12400 NDC 10819-3883-3, UPC (01)00310819000154", "product_quantity": "1982 cases", "reason_for_recall": "SubPotent: Out of Specification", "recall_initiation_date": "20210723", "center_classification_date": "20210820", "termination_date": "20230531", "report_date": "20210901", "code_info": "Lot #'s 11801215, EXP 2021-08-22; 11801504, EXP 2021-11-06; 11801717,EXP 2021-12-07; 11900421, EXP 2022-04-04; 11901076, EXP 2022-08-29; 11901571, EXP 2022-11-19; 12000388, EXP 2023-03-13; 12001533 EXP 2023-07-28;  12100459 EXP 2024-03-31;"}, {"status": "Terminated", "city": "Long Beach", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73304", "recalling_firm": "Hartley Medical Center Pharmacy, Incorporated", "address_1": "113 W Victoria St", "address_2": "N/A", "postal_code": "90805-2162", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide. No foreign distribution.", "recall_number": "D-0739-2016", "product_description": "Morphine Sulfate 0.5 mg/ml/Baclofen 1000 mcg/ml/, vol. 20 ml syringe, Rx only, Hartley Med Ctr Pharmacy, Long Beach, CA", "product_quantity": "1 syringe", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160204", "center_classification_date": "20160304", "termination_date": "20160809", "report_date": "20160316", "code_info": "BUD: 5/3/2016"}, {"status": "Terminated", "city": "Yuyao", "state": "N/A", "country": "China", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "83018", "recalling_firm": "NingBo Huize Commodity Co.,Ltd.", "address_1": "14 Lizhou Road", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Foreign manufacturer located in China and distributed to seven consignees located in China.", "recall_number": "D-1531-2019", "product_description": "Tootsie Roll POP GRAPE SCENTED ANTIBACTERIAL HAND GEL (Ethyl Alcohol 62%), 1.35 fl oz / 40 mL, OTC, Distributed By: JFL Enterprises, Inc. Cleveland, Ohio 44102, Made in China", "product_quantity": "5112", "reason_for_recall": "CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.", "recall_initiation_date": "20190401", "center_classification_date": "20190727", "termination_date": "20230606", "report_date": "20190807", "code_info": "Lot #: 20181018, Exp 10/17/2020"}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-958-2013", "product_description": "FREAMINE III ALT. 8.5% INJECTABLE, all presentations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "03262013@11, 01212013@12, 02112013@17, 02262013@7, 03012013@17, 04102013@8, 04112013@7, 04292013@20, 05212013@4, 06042013@12, 06202013@3, 07152013@19, 07242013@14,", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0745-2020", "product_description": "HYDROMORPHONE 4MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12182019@6 Exp. 12/27/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0721-2023", "product_description": "vancomycin added to dextrose 5%, 1.5 g/250 mL* (6 mg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-6075-1.", "product_quantity": "10282 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-883196, 37-883197, 37-883205, Exp 04/30/2023; 37-884882, 37-884890, 37-884898, Exp 05/07/2023; 37-886840, 37-886858, 37-886863, Exp 05/15/2023; 37-887365, Exp 05/16/2023; 37-887663, Exp 05/17/2023; 37-888254, 37-888257, 37-888265, 37-888303, Exp 05/21/2023; 37-889453, Exp 05/24/2023; 37-890037, 37-890039, 37-890043, Exp 05/28/2023; 37-890330, 37-890333, 37-890344, Exp 05/29/2023; 37-892009, 37-892011, 37-892016, Exp 06/05/2023; 37-892881, Exp 06/07/2023; 37-893448, Exp 06/11/2023; 37-895221, Exp 06/18/2023; 37-898530, Exp 06/29/2023"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0640-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Ileocecal Valve Detox, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955509820, NDC 57955-6083-2", "product_quantity": "500 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 060116E Exp. 06/19; 083017F Exp. 08/19; 101716E Exp. 10/19"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80097", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "111 S Calvert St Fl 21ST", "address_2": "N/A", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0837-2018", "product_description": "My Way (Levonorgestrel) Tablets TWO PACK, 1.5 mg each, packaged as 2 Treatments (Two 1.5mg Levonorgestrel Tablets) per carton, GAVIS Pharmaceuticals, A Lupin Group Company; Mfg. for Lupin Pharmaceuticals, Inc., Baltimore, MD  21202, UPC 3 43386-622-31 3.", "product_quantity": "43,922 cartons", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: 2-pack configuration did not receive appropriate regulatory approval prior to release.", "recall_initiation_date": "20180517", "center_classification_date": "20180531", "termination_date": "20190501", "report_date": "20180530", "code_info": "Lot #: M16317A1, M16317A4, M16317A5, Exp 11/18"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0850-2023", "product_description": "Tobramycin Inhalation Solution USP, 300 mg/5 mL, 4 single-dose ampules, Rx only, Manufactured by: Akorn, Inc, Lake Forest, IL 60045. ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0385-2020", "product_description": "CVS Health Lubricant Eye Ointment, Sterile, Net Wt. 0.125 oz. (3.5 g), Item #247781, Distributed by: CVS Pharmacy Inc., One CVS Drive, Woonsocket, RI 02895", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: SAS 1/21  SIA 9/21  SFE 6/21  SAS 1/21  SFE 6/21  SIA 9/21  RIE 9/20  REH 5/20  RAD 1/20  TAH 1/22"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0673-2023", "product_description": "Cardioplegia Solution, Modified St Thomas Formula, HIGH POTASSIUM, 122 mEq K, packaged in 1000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-0209-1.", "product_quantity": "329 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-893789, Exp 04/28/2023; 37-894318, Exp 04/29/2023; 37-895648, Exp 05/05/2023; 37-897301, Exp 05/12/2023; 37-898815, Exp 05/18/2023"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0547-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Shellfish & Seafood Intolerances, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955520122, NDC 57955-0726-2", "product_quantity": "41 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 032216A Exp. 03/19; 063016L Exp. 06/19"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "54 ml", "code_info": "All lots distributed between November 2014 and May 2015;    05062015@65, 10/6/2015; 04162015@52, 10/13/2015; 03132015@16, 9/9/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Testosterone Cypionate 100 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1640-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89464", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0485-2022", "product_description": "Pain Away Pain Reliever/Fever Reducer (NSAID) (acetaminophen 110 mg, aspirin 162 mg, salicylamide 152mg, caffeine 32.4 mg), 2 tablets per packet, Mfg, for Respond Industries and American First Aid, Mason, OH 45040", "product_quantity": "1,186,000 packets", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220124", "center_classification_date": "20220131", "termination_date": "20231016", "report_date": "20220209", "code_info": "Lot #: AK9493, Exp. Date 02/2022"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204022"], "brand_name": ["ROPINIROLE"], "generic_name": ["ROPINIROLE"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-232", "16729-233", "16729-234", "16729-235", "16729-236", "16729-237", "16729-238"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ROPINIROLE HYDROCHLORIDE"], "rxcui": ["283858", "312845", "312846", "312847", "312849", "314208", "562704"], "spl_id": ["23980eef-2eb5-2b74-e063-6394a90a68ac"], "spl_set_id": ["4a2a5b63-5b14-6975-e054-00144ff8d46c"], "package_ndc": ["16729-232-01", "16729-233-01", "16729-234-01", "16729-235-01", "16729-236-01", "16729-237-01", "16729-238-01"], "is_original_packager": [true], "unii": ["D7ZD41RZI9"], "upc": ["316729235013"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0428-2023", "product_description": "rOPINIRole Tablets USP 2 mg*, 100-count bottle, Rx Only,  Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 INDIA. NDC 16729-235-01, UPC 3 16729 23501 3", "product_quantity": "25,344 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: P2106370, P2106369, Exp. Date 9/30/2023, P2201254, Exp. Date 2/29/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0279-2021", "product_description": "Vecuronium Bromide for Injection, 10 mg, 1 mg/mL when reconstituted to 10 mL, 10 mL Vial (NDC 0703-2914-01), packaged in 10 x 10 mL Vials per tray (NDC 0703-2914-03), Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA  19454.", "product_quantity": "33,6697 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot #   31325712B, exp. date 12/2021  31326320B, exp. date 02/2022  31326457B, exp. date 02/2022  31327880B, exp. date 10/2022"}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89322", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "N/A", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two direct accounts in MI and PA.", "recall_number": "D-0360-2022", "product_description": "Cefixime 400 mg capsule, packaged in a) 2-count bottle (NDC 70518-2749-02), b) 2-count blister pack (NDC 70518-2749-03), Rx only, MFG: Ascend Labs, LLC, Montvale, NJ 07645", "product_quantity": "a) 716 bottles/ 1432 capsules b) 223 blister packs/ 466 capsules", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20211229", "center_classification_date": "20220105", "termination_date": "20220414", "report_date": "20220112", "code_info": "Lot #: a) B1429436-110821, Exp 07/2022; B1429434-110821, Exp 11/2022;  B1429435-110821, Exp 11/2022;  B1279449-072021, Exp 07/2022; B1279457-072021, Exp 07/2022; B1279442-072021,Exp 07/2022; B1057718-012621, Exp 01/2022; B1057727-012621, Exp 01/2022; b) B1358139-092121, Exp 03/2022; B1424654-110421, B1437578-111421, Exp 05/2022"}, {"status": "Terminated", "city": "Nashville", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68557", "recalling_firm": "John W Hollis Inc", "address_1": "110 20th Ave N", "address_2": "N/A", "postal_code": "37203-2315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1395-2014", "product_description": "Levocarnitine Solution for injection, l-Carnitine 50 mg, Also Contains Sterile Water for Injection and Benzyl Alcohol pH adjusted with HCl, 50 mL, JOHN HOLLIS Pharmacist, Inc. 110 20th Avenue N, Nashville, TN 37203, 615-327-3234", "product_quantity": "1750 mL", "reason_for_recall": "Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.", "recall_initiation_date": "20140512", "center_classification_date": "20140618", "termination_date": "20140702", "report_date": "20140625", "code_info": "Lot: 1731, Use by 7/01/14; Lot: 2190, Use by 8/24/14", "more_code_info": ""}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-208-2014", "product_description": "Methylcobalamin 1mg/ml 30ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "24 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA076557"], "brand_name": ["KIRKLAND SIGNATURE ALLERCLEAR D 24 HR"], "generic_name": ["LORATADINE AND PSEUDOEPHEDRINE SULFATE"], "manufacturer_name": ["Kirkland-COSTCO WHOLESALE COMPANY"], "product_ndc": ["63981-724"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["LORATADINE", "PSEUDOEPHEDRINE SULFATE"], "rxcui": ["1117562", "1369756"], "spl_id": ["ebc90414-74b9-4186-99af-b1e655f177eb"], "spl_set_id": ["b8e35d9f-5ad7-4cd5-b359-18f7dfe586c6"], "package_ndc": ["63981-724-15"], "is_original_packager": [true], "unii": ["7AJO3BO7QN", "Y9DL7QPE6B"]}, "product_type": "Drugs", "event_id": "88806", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0069-2022", "product_description": "AllerClear D-24 hr, (Loratadine and Pseudoephedrine Sulfate, Extended-Release Tablets, USP 10/240mg), 15-count blister packs, Manufactured by: Ohm Laboratories Inc., 1385 Livingston Avenue, North Brunswick, NJ 08902, NDC 63981-724-15", "product_quantity": "46,584 blister packs", "reason_for_recall": "Failed Moisture Limits", "recall_initiation_date": "20211012", "center_classification_date": "20211026", "termination_date": "20230831", "report_date": "20211103", "code_info": "AC09723, Exo, Date 11/2022"}, {"status": "Terminated", "city": "Cary", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66297", "recalling_firm": "Triangle Compounding", "address_1": "3700 Regency Pkwy Ste 140", "address_2": "", "postal_code": "27518-8696", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "NC", "recall_number": "D-1068-2013", "product_description": "Sodium Phosphate Injectable, 150mM/50mL Phosphorus 200mEq/50mL Sodium, 50 mL Single Dose Vial, Rx only, Triangle Compounding Pharmacy,  3700 Regency Parkway, Suite 140, Cary NC 27518.", "product_quantity": "54 Vials", "reason_for_recall": "Lack of Assurance of Sterility:The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.", "recall_initiation_date": "20130906", "center_classification_date": "20130930", "termination_date": "20250423", "report_date": "20131009", "code_info": "Lot #814748-LG14917, Exp 10/31/13", "more_code_info": ""}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "11 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #: 07232013@41", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "Phenol, 6%, Injectable, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-438-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0537-2021", "product_description": "Benztropine Mesylate Tablets, USP in all pack sizes, styles and strengths Manufactured for: Qualitest Pharmaceuticals Huntsville, AL 35811", "product_quantity": "60 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "S2008031"}, {"status": "Terminated", "city": "Chatham", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71591", "recalling_firm": "Liberty Drug & Surgical", "address_1": "195 Main St", "address_2": "N/A", "postal_code": "07928-2405", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Physicians, Medical Facilities, and Prescription Specific Patients in NJ and NY", "recall_number": "D-1394-2015", "product_description": "Doxycycline/0.9% NaCl 150 mg/250 mL IV, 250 mL bag, Rx only, Liberty Drug Compound Center, 195 Main St., PO Box 267, Chatham, NJ  07928.", "product_quantity": "112 bags", "reason_for_recall": "Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.", "recall_initiation_date": "20150615", "center_classification_date": "20150827", "termination_date": "20180423", "report_date": "20150902", "code_info": "Lot #: 0513215@12, 05192015@1, 05222015@14, 05222015@15, 05282015@17, 06012015@18, 06022015@19, 06052015@23, Exp 07/06/15"}, {"status": "Terminated", "city": "Conway", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82969", "recalling_firm": "Synthetopes Inc", "address_1": "216 Earnhardt St", "address_2": "N/A", "postal_code": "29526-8287", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1405-2019", "product_description": "Sn-Tetrofosmin Kit 5.0 mL, Thaw and Vent before use, Not for Direct Injection, Store Frozen, Synthetopes, Inc.", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20190528", "center_classification_date": "20190620", "termination_date": "20201015", "report_date": "20190619", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Oberasbach", "state": "N/A", "country": "Germany", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77840", "recalling_firm": "Linde Eckstein Gmbh + Co KG", "address_1": "Flurstrasse 27a-35", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed throughout the United States", "recall_number": "D-1102-2017", "product_description": "Make Up Transparent sand (Titanium Dioxide) SPF 10 liquid make-up, 1 oz. Net Wt. 30 ml bottle, Art. 03220, Made in Germany, Doctor Eckstein, Linde Eckstein GMBH Co. Kg, 90522 Oberasbach, Germany, UPC 4 035219 032203.", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.", "recall_initiation_date": "20170717", "center_classification_date": "20170817", "termination_date": "20180228", "report_date": "20170823", "code_info": "Lot #: 300817, Exp 08/30/2017; 291217, Exp 12/29/2017; 010918, Exp 09/01/2018."}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0419-2017", "product_description": "Tri-Test 200 (CEP 100-75-25) Injectable, 200 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "550 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 04122016@4, 05042016@3, 06012016@8, 06212016@5, 07252016@22."}, {"status": "Ongoing", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87694", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0356-2021", "product_description": "Flurandrenolide Ointment USP, 0.05%,  Net Wt. 60 grams, Rx Only, Teligent Pharma, Inc. Buena, New Jersey 08310 NDC 52565-017-60", "product_quantity": "3432 tubes", "reason_for_recall": "Failed Impurities/Degradation Specifications:", "recall_initiation_date": "20210409", "center_classification_date": "20210428", "report_date": "20210428", "code_info": "Lot #13974 EXP 7/2021", "more_code_info": ""}, {"status": "Terminated", "city": "San Luis Obispo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84284", "recalling_firm": "Integrated Health Concepts Inc. dba Conversio Health", "address_1": "720 Aerovista Pl Ste D", "address_2": "N/A", "postal_code": "93401-8726", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0510-2020", "product_description": "Albuterol 2.5mg / Ipratropium 0.75mg, 2ML Vial, For Inhalation Only, Conversio Health, San Luis Obispo, CA 93401.", "product_quantity": "N/A", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20191112", "center_classification_date": "20191119", "termination_date": "20200528", "report_date": "20191127", "code_info": "All Lots"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; WARFARIN SODIUM, Tablet, 0.5 mg (1/2 of 1 mg) may be potentially mislabeled as    SODIUM CHLORIDE, Tablet, 1 mg, NDC 00223176001, Pedigree: AD70636_1, EXP: 5/29/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "WARFARIN SODIUM, Tablet, 0.5 mg (1/2 of 1 mg) has the following code    Pedigree: AD60590_4, EXP: 5/29/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "WARFARIN SODIUM Tablet, 0.5 mg (1/2 of 1 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 51672402701", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-602-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Jeannette", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80633", "recalling_firm": "Ranier's Compounding Laboratory", "address_1": "1107 Lowry Ave", "address_2": "", "postal_code": "15644-3030", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed within the state of Pennsylvania.", "recall_number": "D-1082-2018", "product_description": "Avastin 1.25 mg/0.05 mL prefilled syringe, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA  15644.", "product_quantity": "213 prefilled syringes", "reason_for_recall": "Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.", "recall_initiation_date": "20180725", "center_classification_date": "20180815", "termination_date": "20220901", "report_date": "20180822", "code_info": "All lots within expiry", "more_code_info": ""}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "73361", "recalling_firm": "Super Herbs", "address_1": "10740 Sw 222nd Dr", "address_2": "N/A", "postal_code": "33170-6544", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "9 consignees - only 9 bottles distributed", "recall_number": "D-0909-2016", "product_description": "SUPER HERBS 350 mg, 30 capsules per bottle.", "product_quantity": "9 bottles", "reason_for_recall": "Marketed without an approved NDA/ANDA - presence of undeclared sibutramine, desmethylsibutramine (an active metabolite of sibutramine) and/or phenolphthalein.", "recall_initiation_date": "20151123", "center_classification_date": "20160526", "termination_date": "20241001", "report_date": "20160601", "code_info": "All lots"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-700-2015", "product_description": "Glipizide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "500 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71553", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave", "address_2": "Suite A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1220-2015", "product_description": "Amlodipine besylate tablets, USP 10 mg, packaged in 10-count blisters (NDC 68084-506-11); 10 blister packs per carton (NDC 68084-506-01); Rx only,  Manufactured by: Wockhardt Limited, Mumbai, India, Distributed by: Wockhardt, USA, LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA for American Health Packaging 2550-A John Glenn Avenue, Columbus, OH 43217.", "product_quantity": "1,745 cartons", "reason_for_recall": "CGMP Deviations: Firm did not adequately investigate customer complaints.", "recall_initiation_date": "20150601", "center_classification_date": "20150708", "termination_date": "20170222", "report_date": "20150715", "code_info": "Lot#: 131953, Exp 07/31/2015"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82398", "recalling_firm": "Advanced Pharma Inc.", "address_1": "9265 Kirby Dr", "address_2": "N/A", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1032-2019", "product_description": "Phenylephrine HCl, 1 mg in Sterile Water for Injection, QS 10 mL Injectable Solution 1 mg/10 mL (100 mcg per mL) NDC: 42852-802-61 Avella of Houston 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404", "product_quantity": "1850 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190313", "center_classification_date": "20190321", "termination_date": "20200114", "report_date": "20190327", "code_info": "Lot: 11/01/18 8847 80261S Exp. 3/31/2019"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0833-2019", "product_description": "Dr. King's SafeCare Rx Odor Freee..., 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955013020, NDC 57955-0130-2", "product_quantity": "23 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 052516G Exp. 05/19"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "22 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  03122015@2, 6/10/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Fentanyl 2,000 mcg/ml Intrathecal Solution, Sterile - Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1494-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021730"], "brand_name": ["LEVALBUTEROL TARTRATE HFA INHALATION"], "generic_name": ["LEVALBUTEROL TARTRATE"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-2927"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVALBUTEROL TARTRATE"], "rxcui": ["745791"], "spl_id": ["f9039b6c-2ae3-416b-bc2a-ab6e06e830bf"], "spl_set_id": ["ac85703a-17a2-4f0b-87f4-78f1756d2f85"], "package_ndc": ["0591-2927-54"], "is_original_packager": [true], "unii": ["ADS4I3E22M"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0580-2021", "product_description": "Levalbuterol tartrate HFA Inhalation Aerosol 45 mcg/actuation 200 Metered Inhalations Net Contents: 15 g Rx Only NDC 0591-2927-54 Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA", "product_quantity": "828 inhalers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "200093"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "85357", "recalling_firm": "Noven Therapeutics, LLC", "address_1": "11960 Sw 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the US", "recall_number": "D-1248-2020", "product_description": "Daytrana (methylphenidate transdermal system) Delivers 20 mg over 9 hours (2.2 mg/hr) 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC Miami, FL 33186, NDC 68968-5554-3", "product_quantity": "5,614 30-count boxes", "reason_for_recall": "Defective Delivery System: Out of specification for mechanical peel and shear.", "recall_initiation_date": "20200331", "center_classification_date": "20200417", "termination_date": "20240617", "report_date": "20200429", "code_info": "Lot: 86354 Exp. 08/2020"}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81218", "recalling_firm": "Sprayology", "address_1": "18914 Bonanza Way", "address_2": "N/A", "postal_code": "20879-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0112-2019", "product_description": "Cold + Flu Relief, Homeopathic Oral Spray, 1.38 fl. oz (41ml), Manufactured for Sprayology Gaithersburg. MD 20879. NDC 61096-0002-1", "product_quantity": "2,565 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20181009", "center_classification_date": "20181030", "termination_date": "20190418", "report_date": "20181107", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0103-2015", "product_description": "Morphine sulfate (PF) 20 mg/mL injectable packaged in 30 mL or 60 mL syringes, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "40 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 07302014@31, Exp 10/28/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77869", "recalling_firm": "The Harvard Drug Group", "address_1": "17177 N Laurel Park Dr Ste 233", "address_2": "", "postal_code": "48152-3951", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1122-2017", "product_description": "Rugby Aller-chlor (Chlorpheniramine Maleate Syrup, USP), 2 mg, 4 fl. oz. (120 mL) plastic bottles, Distributed by:  Rugby Laboratories 17177 N. Laurel Park Drive, Suite 233, Livonia, MI 48152 USA --- NDC: 0536-1025-47", "product_quantity": "4,715 bottles", "reason_for_recall": "Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination", "recall_initiation_date": "20170802", "center_classification_date": "20170824", "termination_date": "20240716", "report_date": "20170830", "code_info": "Item # 370339, all lots", "more_code_info": ""}, {"status": "Terminated", "city": "Brampton", "state": "", "country": "Canada", "classification": "Class II", "openfda": {"application_number": ["ANDA074904"], "brand_name": ["DESOXIMETASONE"], "generic_name": ["DESOXIMETASONE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["51672-1261", "51672-1271", "51672-1270"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["DESOXIMETASONE"], "rxcui": ["197573", "197574", "315059"], "spl_id": ["38f63e0c-c4d2-523e-e063-6394a90a0272"], "spl_set_id": ["37eb1205-1743-4480-8631-b0bbcaeb8359"], "package_ndc": ["51672-1271-1", "51672-1271-2", "51672-1271-3", "51672-1271-7", "51672-1270-1", "51672-1270-2", "51672-1270-3", "51672-1270-7", "51672-1261-1", "51672-1261-2", "51672-1261-3"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["4E07GXB7AU"]}, "product_type": "Drugs", "event_id": "75349", "recalling_firm": "Taro Pharmaceuticals, Inc.", "address_1": "130 East Dr", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US & Puerto Rico", "recall_number": "D-0117-2017", "product_description": "Desoximetasone Cream USP, 0.05% 100 g, Rx only, mfd. by Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532; NDC 51672-1271-7", "product_quantity": "6,756 units", "reason_for_recall": "Failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separation).", "recall_initiation_date": "20160913", "center_classification_date": "20161101", "termination_date": "20180615", "report_date": "20161109", "code_info": "Lot #: E0598-19624, E5099-19624, Exp. Jan 2017", "more_code_info": ""}, {"status": "Terminated", "city": "Augusta", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64661", "recalling_firm": "Clinical Specialties Compounding Pharmacy", "address_1": "318 Baston Rd", "address_2": "N/A", "postal_code": "30907", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "FL, GA and SC.", "recall_number": "D-634-2013", "product_description": "Acetylcysteine 2 % Solution,  Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907", "product_quantity": "10ml", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130320", "center_classification_date": "20130703", "termination_date": "20170222", "report_date": "20130710", "code_info": "Lot number CABDBDAC:98, Exp date: 8/12/2013"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89798", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0679-2022", "product_description": "Diclofenac Sodium Topical Solution USP, 1.5% w/w, 5 fl. oz. (150 mL) bottle, Rx only, Teligent Pharma, Inc., Buena, New Jersey 08310, NDC 52565-002-05.", "product_quantity": "16,643 bottles", "reason_for_recall": "cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.", "recall_initiation_date": "20220315", "center_classification_date": "20220321", "termination_date": "20240617", "report_date": "20220330", "code_info": "Batch: 15066, 15389 Exp. 3/31/2023; 15437, Exp. 12/31/2023; 16823, Exp. 4/30/2024; 16825, 16826, Exp. 4/30/2024"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0199-2022", "product_description": "TRI-MIX PAPAVERINE 30/PHENTOLAMINE 0.5/PGE-1 10 INJ  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "4 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 06252021:39 BUD: 10/23/2021; 08132021:31 BUD: 02/08/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81810", "recalling_firm": "Promise Pharmacy, LLC", "address_1": "31818 Us Highway 19 N", "address_2": "N/A", "postal_code": "34684-3713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0462-2019", "product_description": "HCG, Human chorionic gonadotropin 2,000 units, injection, Rx Only, Promise Pharmacy Compounding Specialists 31818 US Hwy 19N, Palm Harbor, FL 34684", "product_quantity": "819 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20181217", "center_classification_date": "20190208", "termination_date": "20210330", "report_date": "20190220", "code_info": "Lots: 07172018@15 BUD: 1/13/2019; 08272018@3 BUD: 2/23/2019"}, {"status": "Terminated", "city": "Charlotte", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82620", "recalling_firm": "CMC Enterprise Pharmacy", "address_1": "4400 Golf Acres Dr", "address_2": "N/A", "postal_code": "28208-5968", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NC", "recall_number": "D-1223-2019", "product_description": "Lidocaine 1% - Sodium Bicarbonate 8.4% 1:1, 1 mL syringe, For Intradermal Use Only, Made by: Enterprise Pharmacy, 4400 Golf Acres Drive, Bldg. J Suite E, Charlotte, NC, 28208.", "product_quantity": "1135 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190412", "center_classification_date": "20190423", "termination_date": "20191030", "report_date": "20190501", "code_info": "Lots: ED041902 Exp. 4/13/2019; ED051903 Exp. 04/14/2019; ED081902 Exp. 4/17/2019; ED091902 Exp. 4/18/2019; ED101903 Exp. 4/19/2019; ED111902 Exp. 4/20/2019"}, {"status": "Completed", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077651"], "brand_name": ["ZONISAMIDE"], "generic_name": ["ZONISAMIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-128", "68462-129", "68462-130"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ZONISAMIDE"], "rxcui": ["314285", "403966", "403967"], "spl_id": ["c00ccc2d-52c6-4a11-a310-d8db25ca3928"], "spl_set_id": ["fe15e56e-8b86-4a65-825c-31d37dd81612"], "package_ndc": ["68462-128-01", "68462-128-05", "68462-129-01", "68462-129-05", "68462-130-01", "68462-130-05"], "is_original_packager": [true], "upc": ["0368462130018", "0368462129012", "0368462128015"], "nui": ["N0000175753", "N0000008486", "M0020790", "N0000000235", "N0000185503"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "unii": ["459384H98V"]}, "product_type": "Drugs", "event_id": "90029", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-0792-2022", "product_description": "Zonisamide Capsules, USP, 50 mg, packaged in 100-count bottles, Rx only, Manufactured by: Glenmark Pharmaceuticals, Inc., USA Monroe, NC 28110, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-129-01", "product_quantity": "12,003 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220425", "center_classification_date": "20220427", "report_date": "20220504", "code_info": "Lot #: 29200064, Exp 5/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0809-2022", "product_description": "ST-1, Papaverine 30 mg/mL . Phentolamine 1.5 mg/mL . Alprostadil 50 mcg/ml, 10 mL Multi-Dose vial, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0011-10.", "product_quantity": "525 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: H24F03 BUD: 8/3/2022, H24E03 BUD: 8/3/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-721-2015", "product_description": "Hydroxyprogesterone Caproate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "5500 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Ongoing", "city": "Lexington", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95823", "recalling_firm": "Neogen Corporation", "address_1": "1847 Mercer Rd Ste A", "address_2": "", "postal_code": "40511-1001", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product sold directly to one distributor consignee, Bob Barker Company, an American company that sells supplies to prisons, jails, and other institutions.", "recall_number": "D-0073-2025", "product_description": "LICEOUT, Liquid Lice Treatment for Human Use, Contents: 1 FL. OZ. (29.6 mL) per sachet, Distributed By: Bob Barker Company, Inc., 7925 Purfoy Road, Fuquay-Varina, NC 27526.  NDC: 53427-124-01", "product_quantity": "5,328 sachets", "reason_for_recall": "CGMP violations.", "recall_initiation_date": "20241008", "center_classification_date": "20241127", "report_date": "20241204", "code_info": "Lot LO09530; Exp 9/5/2025", "more_code_info": ""}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.", "address_2": "", "product_quantity": "12 bags", "code_info": "Lot: 12/20/18 1056 73099P, BUD: 02/03/2019", "center_classification_date": "20190215", "distribution_pattern": "Nationwide in the USA.", "state": "TX", "product_description": "Oxytocin 10 Units added to NS 1000 mL (oxytocin and 0.9% Sodium Chloride) Injectable Solution, Approximately 1001 mL Sterile single use bag, Rx only,  Avella of Houston, 9265 Kirby Dr., Houston, TX 77054, NDC 42852-730-99.", "report_date": "20190227", "classification": "Class III", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0497-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "82089", "termination_date": "20191030", "more_code_info": "", "recall_initiation_date": "20190206", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0922-2022", "product_description": "Cyanocobalamin 2 mg/mL, Multi-Dose 10 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0115-10", "product_quantity": "1282 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lots: B24115-22 BUD: 8/15/2022; L24001 BUD: 6/1/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Scott", "state": "LA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78669", "recalling_firm": "Intrathecal Compounding Specialist, LLC", "address_1": "206 Jacobs Run", "address_2": "N/A", "postal_code": "70583-8907", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0322-2018", "product_description": "All sterile drug preparations remaining within expiry prepared from Morphine Sulfate PF Base Solution dispensed between October 16, 2017 and November 17, 2017, Compounded by Intrathecal Compounding Specialists, Scott, LA 70583.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171130", "center_classification_date": "20180204", "termination_date": "20190501", "report_date": "20180214", "code_info": "All lots remaining within expiry (BUD between November 15, 2017 and December 16, 2017)."}, {"country": "United States", "city": "Little Rock", "address_1": "7321 Cantrell Rd", "reason_for_recall": "Lack of Assurance of Sterility - the firm is recalling select sterile drug products.", "address_2": "", "product_quantity": "5067 syringes", "code_info": "Lot: 8995", "center_classification_date": "20161213", "distribution_pattern": "Nationwide", "state": "AR", "product_description": "Rocuronium Bromide 50 mg/5 mL Injection Solution, 5 mL (10 mg/mL) Single-Dose Syringe, Injection Solution For Slow IV Use, Rx Only, Cantrell Drug Co. 7321 Cantrell Rd. Little Rock, AR 72207, NDC 52533-064-15", "report_date": "20161221", "classification": "Class II", "openfda": {}, "recalling_firm": "Cantrell Drug Company", "recall_number": "D-0202-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "75745", "termination_date": "20200429", "more_code_info": "", "recall_initiation_date": "20161118", "postal_code": "72207-4144", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Horseheads", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "94348", "recalling_firm": "X-Gen Pharmaceuticals Inc.", "address_1": "300 Daniel Zenker Dr", "address_2": "", "postal_code": "14845-1014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0434-2024", "product_description": "Cyclophosphamide for Injection, USP, 1g/vial, Lyophilized, Single Dose Vial, Discard unused solution, Cytotoxic Agent, After Reconstitution: For direct intravenous injection or must be further diluted before intravenous infusion, Rx Only, Manufactured for: XGen Pharmaceuticals DJB, Inc., Big Flats, NY 14814, NDC # 39822-0255-01.", "product_quantity": "1332 vials", "reason_for_recall": "Labeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Preparation, Handling, and Administration. The concentration of the reconstituted product is listed as '20 mg per vial.' This information should read: '20 mg per mL'.", "recall_initiation_date": "20240402", "center_classification_date": "20240404", "termination_date": "20250930", "report_date": "20240410", "code_info": "Lot #: CIC2-23001 A, Exp. 11/30/2026", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0544-2017", "product_description": "TRICHLOROACETIC ACID SOLUTION in all strengths including: 10%, 12%, 15 %,  20%, 35%, 70%, and 85%, TRICHLOROCETIC ACID 10%/ LACTIC ACID 12%, TRICHLOROCETIC ACID 6%/LACTIC ACID 12%, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0178-2015", "product_description": "BEVACIZUMAB/DEXAMETHASONE, 1.25/0.5 mL, Injectable, 0.05 mL plastic syringe, RX, Creative Compounds, Wilsonville, OR 97070.", "product_quantity": "2.65 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140916@3, discard date: 12/15/2014."}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90718", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1347-2022", "product_description": "PF-Labetalol HCl Injection, USP, 20 mg/4 mL (5 mg/mL), One 4 mL Unit-Dose Vial, packaged in 30 x 4 mL Sterile Unit-dose Vials per carton, Rx Only, Nephron 503B Outsourcing Facility, 4500 12th Street Extension, West Columbia, SC 29172; NDC 69374-946-34", "product_quantity": "33,870 vials", "reason_for_recall": "CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.", "recall_initiation_date": "20220810", "center_classification_date": "20220816", "termination_date": "20241011", "report_date": "20220824", "code_info": "Lot: LB2005A, Exp 3/2/2023", "more_code_info": ""}, {"country": "United States", "city": "Skillman", "address_1": "199 Grandview Rd", "reason_for_recall": "Defective Container: products showed leakage (bubbles, foaming) of propellant and product from the container valve cup area.", "address_2": "", "product_quantity": "", "code_info": "Lot #:15917F54, 16017F54, Exp. 05/2019; 15817F69,15917F69, Exp. 04/2019;  20017F55,  20117F55, Exp. 06/2019.", "center_classification_date": "20180129", "distribution_pattern": "Product was distributed nationwide", "state": "NJ", "product_description": "Neutrogena deep clean purifying whipped foam cleanser, (Salicylic Acid 0.5%), aerosolized product in a can, NET WT. 5 OZ. (141 g) Distributed By: Johnson & Johnson Consumer Inc. Skillman, NJ 08558. UPC: 0 70501 10053 0", "report_date": "20180207", "classification": "Class II", "openfda": {}, "recalling_firm": "Johnson & Johnson", "recall_number": "D-0244-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "78610", "termination_date": "20190909", "more_code_info": "", "recall_initiation_date": "20171207", "postal_code": "08558-1311", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0117-2022", "product_description": "HYDROXOCOBALAMIN 1,000MCG/ML INJ  VIAL 1,000MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "2 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 09102021:19 BUD: 11/09/2021", "more_code_info": ""}]